View Future GrowthEncres Dubuit 過去の業績過去 基準チェック /06Encres Dubuitの収益は年間平均-63.8%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間4.4% 1.2%割合で 減少しています。主要情報-63.83%収益成長率-63.25%EPS成長率Chemicals 業界の成長12.41%収益成長率-1.24%株主資本利益率-29.77%ネット・マージン-24.59%前回の決算情報31 Dec 2025最近の業績更新Reported Earnings • May 08Full year 2023 earnings releasedFull year 2023 results: Revenue: €19.9m (down 12% from FY 2022). Net loss: €2.23m (loss widened €2.06m from FY 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany.すべての更新を表示Recent updatesお知らせ • May 19Encres Dubuit, Annual General Meeting, Jun 15, 2026Encres Dubuit, Annual General Meeting, Jun 15, 2026. Location: 1 rue isaac newton zi mitry compans, mitry mory FranceNew Risk • May 18New major risk - Revenue and earnings growthEarnings have declined by 64% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 64% per year over the past 5 years. Market cap is less than US$10m (€6.32m market cap, or US$7.35m).お知らせ • May 22Encres Dubuit, Annual General Meeting, Jun 26, 2025Encres Dubuit, Annual General Meeting, Jun 26, 2025. Location: 1 rue isaac newton, mitry mory FranceNew Risk • Mar 31New major risk - Revenue and earnings growthEarnings have declined by 51% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 51% per year over the past 5 years. Market cap is less than US$10m (€8.45m market cap, or US$9.13m).New Risk • Nov 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€8.69m market cap, or US$9.18m). Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).お知らせ • May 09Encres Dubuit, Annual General Meeting, Jun 13, 2024Encres Dubuit, Annual General Meeting, Jun 13, 2024. Location: zone industrielle de mitry compans, 1 rue isaac newton, mitry mory FranceReported Earnings • May 08Full year 2023 earnings releasedFull year 2023 results: Revenue: €19.9m (down 12% from FY 2022). Net loss: €2.23m (loss widened €2.06m from FY 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany.New Risk • Feb 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.25m (US$9.97m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Market cap is less than US$10m (€9.25m market cap, or US$9.97m).Buying Opportunity • Nov 11Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be €4.22, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.7% over the last 3 years. Meanwhile, the company became loss making.収支内訳Encres Dubuit の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史MUN:1F2 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Dec 2518-48030 Sep 2518-38031 Dec 2420-18030 Sep 2420-18030 Jun 2420-28031 Mar 2420-28031 Dec 2320-28030 Sep 2321-28030 Jun 2322-18031 Mar 2322-18031 Dec 222308030 Sep 222208030 Jun 222118031 Mar 222118031 Dec 212117030 Sep 212017030 Jun 212007031 Mar 211907031 Dec 2019-17030 Sep 2019-17030 Jun 2020-17031 Mar 202207031 Dec 192407030 Sep 192418030 Jun 192518031 Mar 192518031 Dec 182517030 Sep 182417030 Jun 182317031 Mar 182317031 Dec 172217031 Dec 162117031 Mar 162127031 Dec 152127030 Sep 1521260質の高い収益: 1F2は現在利益が出ていません。利益率の向上: 1F2は現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 1F2は利益が出ておらず、過去 5 年間で損失は年間63.8%の割合で増加しています。成長の加速: 1F2の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: 1F2は利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( -13.5% ) と比較することは困難です。株主資本利益率高いROE: 1F2は現在利益が出ていないため、自己資本利益率 ( -29.77% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 19:20終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Encres Dubuit 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Stephanie LefebvreGilbert DupontSandrine CauvinGilbert Dupont
Reported Earnings • May 08Full year 2023 earnings releasedFull year 2023 results: Revenue: €19.9m (down 12% from FY 2022). Net loss: €2.23m (loss widened €2.06m from FY 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany.
お知らせ • May 19Encres Dubuit, Annual General Meeting, Jun 15, 2026Encres Dubuit, Annual General Meeting, Jun 15, 2026. Location: 1 rue isaac newton zi mitry compans, mitry mory France
New Risk • May 18New major risk - Revenue and earnings growthEarnings have declined by 64% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 64% per year over the past 5 years. Market cap is less than US$10m (€6.32m market cap, or US$7.35m).
お知らせ • May 22Encres Dubuit, Annual General Meeting, Jun 26, 2025Encres Dubuit, Annual General Meeting, Jun 26, 2025. Location: 1 rue isaac newton, mitry mory France
New Risk • Mar 31New major risk - Revenue and earnings growthEarnings have declined by 51% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 51% per year over the past 5 years. Market cap is less than US$10m (€8.45m market cap, or US$9.13m).
New Risk • Nov 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€8.69m market cap, or US$9.18m). Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).
お知らせ • May 09Encres Dubuit, Annual General Meeting, Jun 13, 2024Encres Dubuit, Annual General Meeting, Jun 13, 2024. Location: zone industrielle de mitry compans, 1 rue isaac newton, mitry mory France
Reported Earnings • May 08Full year 2023 earnings releasedFull year 2023 results: Revenue: €19.9m (down 12% from FY 2022). Net loss: €2.23m (loss widened €2.06m from FY 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany.
New Risk • Feb 10New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.25m (US$9.97m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Market cap is less than US$10m (€9.25m market cap, or US$9.97m).
Buying Opportunity • Nov 11Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be €4.22, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.7% over the last 3 years. Meanwhile, the company became loss making.